###begin article-title 0
###xml 30 35 <span type="species:ncbi:9606">human</span>
Structure and function of the human Gly1619Arg polymorphism of M6P/IGF2R domain 11 implicated in IGF2 dependent growth
###end article-title 0
###begin p 1
###xml 1268 1270 1268 1270 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
The mannose 6-phosphate/IGF 2 receptor (IGF2R) is comprised of 15 extra-cellular domains that bind IGF2 and mannose 6-phosphate ligands. IGF2R transports ligands from the Golgi to the pre-lysosomal compartment and thereafter to and from the cell surface. IGF2R regulates growth, placental development, tumour suppression and signalling. The ligand IGF2 is implicated in the growth phenotype, where IGF2R normally limits bioavailability, such that loss and gain of IGF2R results in increased and reduced growth respectively. The IGF2R exon 34 (5002A>G) polymorphism (rs629849) of the IGF2 specific binding domain has been correlated with impaired childhood growth (A/A homozygotes). We evaluated the function of the Gly1619Arg non-synonymous amino acid modification of domain 11. NMR and X-ray crystallography structures located 1619 remote from the ligand binding region of domain 11. Arg1619 was located close to the fibronectin type II (FnII) domain of domain 13, previously implicated as a modifier of IGF2 ligand binding through indirect interaction with the AB loop of the binding cleft. However, comparison of binding kinetics of IGF2R, Gly1619 and Arg1619 to either IGF2 or mannose 6-phosphate revealed no differences in 'on' and 'off' rates. Quantitative PCR, 35S pulse chase and flow cytometry failed to demonstrate altered gene expression, protein half-life and cell membrane distribution, suggesting the polymorphism had no direct effect on receptor function. Intronic polymorphisms were identified which may be in linkage disequilibrium with rs629849 in certain populations. Other potential IGF2R polymorphisms may account for the correlation with childhood growth, warranting further functional evaluation.
###end p 1
###begin title 2
Introduction
###end title 2
###begin p 3
###xml 118 119 118 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 302 307 302 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 296 313 296 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib19">Ghosh <italic>et al</italic>. 2003</xref>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 338 343 <span type="species:ncbi:10090">mouse</span>
The human mannose 6-phosphate/IGF2 receptor (IGF2R) is a large (270 kDa) multi-functional type I membrane protein and P-type lectin. The 15 extra-cellular domains of IGF2R bind ligands that are shuttled from the Golgi to the pre-lysosomal compartment and thereafter to and from the cell surface (Ghosh et al. 2003). Functional studies in mouse models have shown that IGF2R ligands are involved in embryonic growth, placental development, tumour suppression and signalling.
###end p 3
###begin p 4
###xml 279 301 270 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">Dennis and Rifkin 1991</xref>
###xml 311 316 302 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 322 323 313 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 303 323 294 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib20">Hancock <italic>et al</italic>. 2002<italic>a</italic></xref>
###xml 325 326 316 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 325 326 316 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21"><italic>b</italic></xref>
###xml 334 339 325 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 328 345 319 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib19">Ghosh <italic>et al</italic>. 2003</xref>
###xml 450 453 429 432 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;10</sup>
###xml 597 602 576 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 589 608 568 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib33">Linnell <italic>et al</italic>. 2001</xref>
###xml 619 624 598 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 610 630 589 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib43">Williams <italic>et al</italic>. 2007</xref>
###xml 638 643 617 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 632 649 611 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">Brown <italic>et al</italic>. 2008</xref>
###xml 1033 1038 1012 1017 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1025 1044 1004 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">Conover <italic>et al</italic>. 2004</xref>
###xml 1201 1206 1180 1185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1195 1212 1174 1191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">Brown <italic>et al</italic>. 2008</xref>
###xml 1408 1413 1387 1392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1398 1419 1377 1398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">Foulstone <italic>et al</italic>. 2005</xref>
###xml 1588 1592 1567 1571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Igf2</italic>
###xml 1599 1604 1578 1583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1594 1610 1573 1589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib42">Wang <italic>et al</italic>. 1994</xref>
###xml 1619 1624 1598 1603 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1612 1630 1591 1609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">Ludwig <italic>et al</italic>. 1996</xref>
###xml 1812 1816 1791 1795 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Igf2</italic>
###xml 1852 1857 1831 1836 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1840 1863 1819 1842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">Christofori <italic>et al</italic>. 1994</xref>
###xml 1874 1879 1853 1858 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1865 1885 1844 1864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">De Souza <italic>et al</italic>. 1995</xref>
###xml 1895 1900 1874 1879 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1887 1906 1866 1885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">Hankins <italic>et al</italic>. 1996</xref>
###xml 1913 1918 1892 1897 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1908 1924 1887 1903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib15">Devi <italic>et al</italic>. 1999</xref>
###xml 1931 1936 1910 1915 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1926 1942 1905 1921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">Kong <italic>et al</italic>. 2000</xref>
###xml 1951 1956 1930 1935 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1944 1962 1923 1941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib23">Harper <italic>et al</italic>. 2006</xref>
###xml 1429 1434 <span type="species:ncbi:10090">mouse</span>
###xml 1690 1695 <span type="species:ncbi:9606">human</span>
Mannose 6-phosphate bound to domains 3, 5 and 9 regulates the transport of phosphomannosyl glycoproteins such as lysosomal proteases, and latent transforming growth factor beta1 (latent-TGFbeta1), where activation of the latter to active TGFbeta1 occurs by proteolytic cleavage (Dennis and Rifkin 1991, Hancock et al. 2002a, b, Ghosh et al. 2003). IGF 2 (IGF2) binds to domain 11 of mammalian IGF2R with high affinity and specificity (approximately10-10 M), with a fibronectin type II region of domain 13 thought to act as an indirect enhancer of affinity through reduction in 'off rate' (Linnell et al. 2001, Williams et al. 2007, Brown et al. 2008). IGF2 is a small hydrophobic ligand (7.5 kDa) that is normally bound to binding proteins (IGFBP's) that regulate bioavailability through proteolytic cleavage. For example, the potent embryonic growth promoting effect of IGF2 depends on the expression of a developmentally expressed protease, PAPPA2, that cleaves binding proteins to release free IGF2 for signal activation (Conover et al. 2004). The binding stochiometry of IGF2 to membrane bound IGF2R is 1:1, and utilises the same binding site on IGF2 that is recognised by binding proteins (Brown et al. 2008). IGF2R sequesters free IGF2 ligand and internalises it for intracellular degradation, and so limits activation of the signalling receptors IGF1R and isoform A of the insulin receptor (Foulstone et al. 2005). In the mouse, loss of function of IGF2R results in disproportionate embryonic overgrowth and perinatal lethality that was rescued by the combination with knockout of Igf2 (Wang et al. 1994, Ludwig et al. 1996). Moreover, loss of function of IGF2R has been observed in human tumours through loss of heterozygosity and functional missense mutations, with genetic models that also confirm the Igf2 dependency of tumours (Christofori et al. 1994, De Souza et al. 1995, Hankins et al. 1996, Devi et al. 1999, Kong et al. 2000, Harper et al. 2006). These results suggest that the growth antagonist effects of IGF2R are principally determined by the reduction in free IGF2 ligand supply.
###end p 4
###begin p 5
###xml 481 486 481 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 470 492 470 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">Kalscheuer <italic>et al</italic>. 1993</xref>
###xml 497 502 497 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 494 508 494 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib46">Xu <italic>et al</italic>. 1993</xref>
###xml 515 520 515 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 510 526 510 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib44">Wutz <italic>et al</italic>. 2001</xref>
###xml 687 692 687 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 683 698 683 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">Cui <italic>et al</italic>. 2003</xref>
###xml 704 709 704 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 700 715 700 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">Ito <italic>et al</italic>. 2008</xref>
###xml 948 953 948 953 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 944 959 944 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31 bib36">Ong <italic>et al</italic>. 2000</xref>
###xml 969 974 969 974 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 961 980 961 980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">Garrone <italic>et al</italic>. 2002</xref>
###xml 339 345 <span type="species:ncbi:9606">humans</span>
###xml 433 438 <span type="species:ncbi:10090">mouse</span>
###xml 609 615 <span type="species:ncbi:9606">humans</span>
###xml 810 815 <span type="species:ncbi:9606">human</span>
The relative abundance of IGF2 and IGF2R are also regulated at the level of gene expression through genomic imprinting. In all mammals, IGF2 is a maternally silenced (imprinted) gene, with paternal allele expression, whereas IGF2R is normally paternally silenced, with maternal allele expression. Unlike other mammals, IGF2R imprinting in humans is a polymorphic trait, with most individuals having bi-allelic expression that in the mouse results in growth retardation (Kalscheuer et al. 1993, Xu et al. 1993, Wutz et al. 2001). Germ line loss of imprinting of IGF2 has been reported to occur in up to 10% of humans and may be associated with an increased risk of colorectal cancer (Cui et al. 2003, Ito et al. 2008). Observational data have also correlated blood concentrations of IGF2 and soluble IGF2R with human birth weight and adult height, suggesting that relative supply of ligand and receptor may result in significant growth effects (Ong et al. 2000, Garrone et al. 2002).
###end p 5
###begin p 6
###xml 285 290 285 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 279 296 279 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib49">Young <italic>et al</italic>. 2001</xref>
###xml 433 438 433 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 425 444 425 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib29">Killian <italic>et al</italic>. 2001</xref>
###xml 738 739 738 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 746 747 746 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 762 767 762 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 754 773 754 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib29">Killian <italic>et al</italic>. 2001</xref>
###xml 1148 1153 1148 1153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1142 1159 1142 1159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib38">Petry <italic>et al</italic>. 2005</xref>
###xml 1371 1376 1371 1376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1364 1382 1364 1382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib39">Savage <italic>et al</italic>. 2007</xref>
###xml 217 222 <span type="species:ncbi:9940">sheep</span>
###xml 412 417 <span type="species:ncbi:9606">human</span>
###xml 711 717 <span type="species:ncbi:9606">humans</span>
###xml 831 839 <span type="species:ncbi:9606">Children</span>
###xml 881 889 <span type="species:ncbi:9606">children</span>
Aside from imprinting, functional dosage of IGF2R may also be modified by polymorphisms that either alters gene expression or protein function. For example, epigenetic mediated reduction in IGF2R expression in cloned sheep accounted for the 'large offspring syndrome' phenotype (Young et al. 2001). Single nucleotide polymorphisms have been identified throughout the 140 Kb locus and the 48 exons and introns of human IGF2R (Killian et al. 2001). Non-synonymous polymorphisms in coding exons have been mapped to specific domains of the protein. For example, the exon 34 (5002A>G) Gly1619Arg polymorphism generates a non-synonymous modification of domain 11 of IGF2R, and exists in Hardy Weinberg equilibrium in humans (allele frequencies A=0.15, G=0.85; Killian et al. 2001). Analysis of the Avon Longitudinal Study of Parents and Children prospective cohort of normal mothers and children suggested that babies born with the rarer AA homozygote alleles exhibited slower growth rate kinetics during the first three years of post-natal development, even though circulating IGF2 levels were similar to GG homozygotes and heterozygote controls (Petry et al. 2005). A comprehensive analysis of SNPs associated with the later development of cancer has been recently reported with IGF2R haplotypes identified that conferred an increased risk of developing osteosarcoma (Savage et al. 2007). In this example, an intron 16 SNP was associated with loss of methylation of a CpG island site that presumably controlled gene expression. The implications of these, and similar SNP association studies, are limited by the lack of functional analysis of associated SNPs, in particular non-synonymous SNPs in ligand binding domains of IGF2R. Here, we report the first comprehensive functional analysis of a non-synonymous IGF2R polymorphism, Gly1619Arg of domain 11, the domain that specifically binds IGF2. We demonstrate that this polymorphism alone has no detectable effects on domain 11 structure, real-time ligand binding kinetics, protein half-life and cell surface distribution. We discuss the implications of these findings with respect to IGF2R function and linkage to other SNPs.
###end p 6
###begin title 7
Material and Methods
###end title 7
###begin title 8
Plasmids, cloning and reagents
###end title 8
###begin p 9
###xml 172 177 172 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 164 183 164 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib33">Linnell <italic>et al</italic>. 2001</xref>
###xml 193 198 193 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 185 204 185 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib50">Zaccheo <italic>et al</italic>. 2006</xref>
###xml 854 856 851 853 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 877 879 874 876 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 976 978 973 975 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 1331 1332 1328 1329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 4 7 <span type="species:ncbi:10116">rat</span>
###xml 729 734 <span type="species:ncbi:9606">human</span>
###xml 1129 1134 <span type="species:ncbi:10090">Mouse</span>
###xml 1140 1143 <span type="species:ncbi:10116">rat</span>
###xml 1172 1177 <span type="species:ncbi:10090">mouse</span>
###xml 1183 1188 <span type="species:ncbi:9606">human</span>
###xml 1241 1245 <span type="species:ncbi:9925">goat</span>
###xml 1251 1256 <span type="species:ncbi:10090">mouse</span>
###xml 1319 1325 <span type="species:ncbi:9986">rabbit</span>
For rat CD4 domains 3 and 4 -IGF2R chimeric constructs (CD4-IGF2R), previously described pEFBOS plasmids containing IGF2R domains 11, 10-13 and 1-15 were utilised (Linnell et al. 2001, Zaccheo et al. 2006). For membrane-bound IGF2R, full IGF2R insert was derived from ATCC (J03528) using primers (FullIGF2RNheIF2) 5'-atatgctagcGCGATGGGGGCCGCCGCC-3' and (FullIGF2RXhoIR2) 5'-gcgcctcgagTCAGATGTGTAAGAGGTCCTCGTCG-3', incorporating NheI and XhoI restriction sites respectively. The product was ligated into the pcDNA 3.1(+) vector to generate pcDNA-IGF2R. pEGFP-N1 plasmid was from Clontech (Saint-Germain-en-Laye, France). Protein biotinylation was performed using the BirA biotin-protein ligase from Avidity (CO, USA). Recombinant human IGF2 was from Novozymes GroPep Ltd., (Adelaide, Australia) and latent-TGFbeta1 was from R&D systems (Abingdon, UK). L-[35S] methionine and L-[35S] cysteine Redivue Pro-Mix (Radioactive concentration 370 MBq/ml (10 mCi/ml) with respect to L-[35S] methionine at the activity reference date were obtained from Amersham. Methionine/Cysteine-free DMEM and Protein G-Sepharose beads were from Sigma. Mouse anti rat-CD4 antibody (MCA1022R) and mouse anti human-IGF2R (MCA2048) were from AbD Serotec (Oxford, UK), goat anti-mouse PE/Cy5 (M32006) was from Caltag Laboratories (Invitrogen) and rabbit anti-E-cadherin was from Santa Cruz Biotechnology Inc., (Heidelberg, Germany). Quick-Change II Site-directed Mutagenesis kit was from Stratagene (Cheshire, UK) and Phusion Site-directed Mutagenesis kit was from Finnzymes (Espoo, Finland). ImProm-II reverse transcription system was from Promega. Surface plasmon resonance (SPR) buffers, chips and consumables were from GE Healthcare (BIAcore, Chalfont, UK). The FACSCalibur system used for flow cytometry was from Becton Dickinson (Oxford, UK).
###end p 9
###begin title 10
Site-directed mutagenesis
###end title 10
###begin p 11
###xml 188 189 188 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 244 245 244 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 528 529 528 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
In the pEFBOS plasmids, Gly1619Arg mutant constructs were generated using the Quick-Change II kit according to the manufacturer's protocols, using primers (G1619R F) 5'-CGTGTGCAGGCCTGAGGCCAGGCCAACCAATAGGCC-3' and (G1619R R) 5'- GGCCTATTGGTTGGCCTGGCCTCAGGCCTGCACACG-3'. For IGF2R domains 11, 10-13 and 1-15 these are termed CD4-11, CD4-10-13 and CD4-1-15. In the pcDNA-IGF2R plasmid, Gly1619Arg mutant constructs were generated using the Phusion kit according to the manufacturer's protocols, using primers (G1619R-phus-F) 5'-GCCAGGCCAACCAATAGGCCCATGCTCATCT-3' and (G1619R-phus-R) 5'-CTCAGGCCTGCACACGAAACTGATCACACTC-3'. The mutations were confirmed by DNA bi-directional sequencing performed by the sequencing service (School of Life Sciences, University of Dundee, Scotland) using Applied Biosystems Big-Dye Version 3.1 chemistry on an Applied Biosystems model 3730 automated capillary DNA sequencer.
###end p 11
###begin title 12
IGF2R domain 11 G1619R
###end title 12
###begin p 13
###xml 159 162 159 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nde</italic>
###xml 168 171 168 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xho</italic>
###xml 357 373 357 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 392 397 392 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 386 403 386 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">Brown <italic>et al</italic>. 2002</xref>
###xml 406 408 406 408 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15</sup>
###xml 472 479 472 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 535 537 535 537 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15</sup>
###xml 539 540 539 540 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 622 627 622 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 613 633 613 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib43">Williams <italic>et al</italic>. 2007</xref>
###xml 357 373 <span type="species:ncbi:562">Escherichia coli</span>
###xml 472 484 <span type="species:ncbi:511693">E. coli BL21</span>
To construct IGF2R domain 11 Gly1619Arg expression vector, domain 11 Gly1619Arg was amplified by PCR from pEFBOS-IGF2R-domain11 Gly1619Arg and cloned into the NdeI and XhoI restriction sites of pET26b (Novagen) using standard methods. The authenticity of the clones was verified by sequencing. Wild-type domain 11 had been previously cloned into pET22b for Escherichia coli expression (Brown et al. 2002). 15N-labelled wild-type and Gly1619Arg domain 11 were expressed in E. coli BL21(DE3) grown in M9 media supplemented with 1 g/l of 15NH4Cl as the sole nitrogen source and refolded using established protocols (Williams et al. 2007). Owing to slightly different cloning strategies, wild-type domain 11 had a C-terminal hexahistidine tag while the Gly1619Arg domain 11 construct lacked any additional amino acids.
###end p 13
###begin title 14
NMR spectroscopy
###end title 14
###begin p 15
###xml 159 160 144 145 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 169 170 154 155 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 176 177 161 162 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 196 197 181 182 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 199 201 184 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15</sup>
###xml 390 391 369 370 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 450 452 429 431 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15</sup>
###xml 499 500 478 479 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 517 519 496 498 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15</sup>
###xml 566 571 545 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 557 577 536 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">Delaglio <italic>et al</italic>. 1995</xref>
###xml 634 639 613 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 626 645 605 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib41">Vranken <italic>et al</italic>. 2005</xref>
NMR samples typically contained approximately 250 muM protein dissolved in 600 mul of 20 mM sodium acetate (pH5.5), 1 mM EDTA, 1 mM benzamidine and 100 muM NaN3 in 95% H2O/5% D2O. Two dimensional 1H-15N heteronuclear single quantum coherence spectra were recorded at 25 degreesC on a Varian 600 MHz INOVA spectrometer equipped with a triple resonance probe. Spectra were acquired with 1024 1H complex points in the t2 dimension and 128 points in the 15N dimension, and spectral widths of 7000 Hz in 1H and 2000 Hz in 15N. Data were processed using NMRPipe (Delaglio et al. 1995) and analysed with CCPN Analysis version 1.015 (Vranken et al. 2005).
###end p 15
###begin title 16
Expression of CD4-IGF2R chimeras and membrane bound IGF2R
###end title 16
###begin p 17
###xml 259 260 258 259 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 288 289 287 288 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 574 579 572 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 568 585 566 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">Davis <italic>et al</italic>. 1990</xref>
###xml 694 699 692 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 686 705 684 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib33">Linnell <italic>et al</italic>. 2001</xref>
###xml 715 720 713 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 707 726 705 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib50">Zaccheo <italic>et al</italic>. 2006</xref>
###xml 991 997 <span type="species:ncbi:9913">bovine</span>
The CD4-IGF2R chimeric constructs were transiently expressed in 293T cells using Fugene 6.0 (Roche). Briefly, 4 mug DNA and in a 6:1 plasmid:Fugene ratio were added to cells and grown for 5 days in serum free media (DMEM; Sigma-D5796) with 4500 mg/l glucose, l-glutamine (584 mg/l), NaHCO3 (3.7 g/l) and pyrodoxyl HCl (4 mg/l) with added 50 u/ml penicillin, 50 mug/ml streptomycin. Spent culture supernatants were collected, and cells were cleared by centrifugation. Cell lysis and recombinant CD4-IGF2R chimeras' detection was with a CD4 sandwich ELISA as described (Davis et al. 1990). Protein biotinylation, SDS PAGE and western blotting were also performed as previously described (Linnell et al. 2001, Zaccheo et al. 2006). The full length IGF2R constructs were transiently co-expressed in 293T cells with eGFP plasmid using lipofectamine (10 mul) (Invitrogen) using 3.6 mug pcDNA-IGF2R and 0.4 mug eGFP-N1 plasmid in antibiotic-free growth media (DMEM with 2mM glutamine and 10% fetal bovine serum). The medium was changed 24 h post-transfection to serum-free medium, and cells were prepared for flow cytometry 48 h post-transfection.
###end p 17
###begin title 18
Surface plasmon resonance kinetic analysis
###end title 18
###begin p 19
###xml 71 76 71 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 63 82 63 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib50">Zaccheo <italic>et al</italic>. 2006</xref>
###xml 863 864 820 821 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1267 1268 1224 1225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 1268 1269 1225 1226 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</sub>
Kinetic analysis by SPR was conducted as previously described (Zaccheo et al. 2006) using a BIAcore 3000 biosensor (BIAcore). All SPR experiments were performed at 25 degreesC in HBS-EP (10 mM Hepes (pH 7.4), 150 mM NaCl, 3 mM EDTA and 0.005% (v/v) surfactant P20) at a flow-rate of 40 mul/min. After pre-conditioning, the sensor chip with three 1 min injections of 1 M NaCl, 50 mM NaOH, either approximately 600 RU of recombinant biotinylated CD4-11, approximately 1600 RU of recombinant biotinylated CD4-10-13 or approximately 3300 RU of recombinant biotinylated CD4-1-15 were immobilised on a Sensor Chip SA by affinity capture to streptavidin. Kinetic experiments consisted of a 2-5 min injection of analyte followed by a 150-200 s dissociation phase in HBS-EP running buffer, after which the binding surface was regenerated with a 2 min injection of 2 M MgCl2. Kinetic parameters were determined by global fitting of sensorgrams to a two-state (conformational change) binding model using BIA evaluation software version 4.0.1. In all cases, the minor component made an insignificant contribution to the overall affinity and, as such, only the kinetic parameters of the major binding component were used. For each interaction, the dissociation affinity constant (KD) were also calculated by fitting of the response of each concentration at equilibrium to a steady-state affinity model using BIAevaluation.
###end p 19
###begin p 20
###xml 232 237 <span type="species:ncbi:9606">human</span>
Using the SA sensor chip with immobilised WT CD4-1-15 and G1619R CD4-1-15, competition assay experiments were run at a flow-rate of 40 mul/min and consisted of a co-inject of a first 100 mul injection of either (130 nM) recombinant human IGF2 or (30 nM) latent TGFbeta1, followed by a second 100 mul injection of a 1:1 mixture of both analytes at the same above concentrations or 1:1 mixture of one analyte with buffer. A control experiment was run on the same sensor chip, where a co-inject of a first 100 mul injection of buffer (HBS-EP), followed by a second 100 mul injection of a 1:1 mixture of each analyte at the same above concentrations with buffer.
###end p 20
###begin p 21
Analysis of the competition experiments were performed by quantifying the amounts of bound analyte from the second injection of each co-inject. This was assessed from the response amplitude (RU) and compared with control injections. For both kinetic and competition analyses, a blank flow-cell was used for in-line reference subtraction of changes due to differences in refractive index of running buffer versus sample and a buffer-only injection was used to subtract instrument noise and drift. Injections were performed in duplicate for each concentration and in a randomised order.
###end p 21
###begin title 22
Quantitative RT PCR
###end title 22
###begin p 23
RNA was extracted from 293T cells 5 days post-transfection, using Trizol (Invitrogen) in accordance with the manufacturer's protocol. The extracted RNA was then treated with DNase (Amplification grade, Invitrogen) and reverse transcribed. Subsequently, real-time PCR was performed using the SYBR Green QuantiTect RT-PCR Kit (Qiagen) and the Mx3000P real-time cycler in accordance with the manufacturer's instructions. Data were analysed in accordance with manufacturers' instructions.
###end p 23
###begin title 24
###xml 1 3 1 3 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 22 24 22 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
[35S]-methionine and [35S]-cysteine pulse-chase
###end title 24
###begin p 25
###xml 9 10 9 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 298 299 291 292 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 660 662 651 653 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 681 683 672 674 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 763 764 748 749 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1050 1051 1034 1035 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 1050 1051 1034 1035 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>g</italic></bold>
###xml 1330 1331 1301 1302 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1637 1638 1602 1603 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 1637 1638 1602 1603 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>g</italic></bold>
###xml 190 196 <span type="species:ncbi:9913">bovine</span>
In 9.5 cm2 6-well plates, 293T cells were transfected by Fugene 6 using 1 mug plasmid DNA and a 6:1 plasmid:Fugene ratio in growth media (DMEM with 2 mM glutamine, antibiotics and 10% fetal bovine serum). Transfected cells were incubated at 37 degreesC in a humidified incubator supplied with 5% CO2 for 24 h prior to initiation of pulse-chase. Cells were first washed twice with PBS and incubated for 30-60 min in 1 ml starvation medium (methionine/cysteine-free DMEM, 50 u/ml penicillin, 50 mug/ml streptomycin and 2 mM glutamine). For metabolic labelling, the starvation medium was replaced with 500 mul/well of pulse medium (starvation medium +0.1 mCi/ml [35S]-methionine and [35S]-cysteine Redivue Pro-Mix) and pulsed for 1 h or 12 h at 37 degreesC and 5% CO2. Metabolic labelling was stopped by adding 500 mul per well of chase medium (starvation medium supplemented with cold 5 mM cysteine and 5 mM methionine), washed and incubated 1 ml per well of chase medium. After the selected chase time, supernatants were recovered, centrifuged at 5000g for 5 min, immediately snap-frozen in liquid nitrogen and stored at -80 degreesC until all chase samples were collected. For each selected chase time, cells were incubated for 30 min on ice (4 degreesC) in 500 mul/well lysis buffer (50 mM Tris-HCL pH 7.4, 150 mM NaCl, 2 mM MgCl2, 1:1000 protease inhibitor cocktail (Sigma P3840), 1:1000 PMSF from a 200 mM Stock in Isopropanol). Cell lysates were then snap frozen in liquid nitrogen and stored at -80 degreesC. For immunoprecipitation (IP), liquid scintillation counting and protein assays, unfrozen samples were centrifuged at 10 600g for 10 min to pellet the nuclei and remove debris. Immuno-precipitation was performed using 20 mul Protein G-Sepharose (2 mg/ml) beads for each sample, where PBS-washed beads and 1 mul antibody were incubated with slow rotation overnight at 4 degreesC with either 250 mul of the recovered supernatants or 50 mul cell lysates in a total volume 600 mul. Pellets were then washed three times with PBS and prepared for SDS-PAGE analysis by final re-suspension in 15 mul/pellet of 5xSample buffer (200 mM Tris-HCl pH 6.8, 10% SDS, 50% glycerol, 5% 2-mercaptoethanol, 0.05% bromophenol blue) and 5 min boiling at 95 degreesC. Immuno-precipitation products were loaded in 5% (w/v) polyacrylamide gels and were run at 200 V for 35 min, dried on 0.5 mm Whatman filter paper in a vacuum-heated gel dryer and exposed to a BioRad phosphor imaging screen.
###end p 25
###begin p 26
Scanning densitometry was used to quantify radioactivity, and values were expressed relative to a loading control of total radioactivity in each sample. The latter was determined by total liquid scintillation counting using PerkinElmer scintillation cocktail (Ultima Gold LLT).
###end p 26
###begin title 27
Flow cytometry
###end title 27
###begin p 28
Cells were detached from plates using 0.1 mM EDTA. For cell surface detection with an intact cell membrane, cells were not fixed or permeablised, however, for total expression, cells were fixed in 1ml paraformaldehyde (2% w/v in PBS, pH 7.4) at 4 degreesC for 30 min and permeablised in 0.1% v/v Triton in 2% w/v paraformaldehyde at 4 degreesC for 30 min.
###end p 28
###begin p 29
###xml 133 138 <span type="species:ncbi:10090">mouse</span>
###xml 144 149 <span type="species:ncbi:9606">human</span>
###xml 320 324 <span type="species:ncbi:9925">goat</span>
###xml 330 335 <span type="species:ncbi:10090">mouse</span>
Cells were treated with 1 ml buffer (1% BSA in PBS) and stained using 100 mul buffer with 1:50 diluted primary antibody (AbD Serotec mouse anti-human IGF2R CD222) and incubated at room temperature for 1 h at 4 degreesC. Cells were than washed and incubated in 100 mul buffer with 1:50 diluted secondary antibody (Caltag goat anti-mouse PE/Cy5) for 1 h at 4 degreesC. Cells were analysed using a Becton Dickinson FACSCalibur system and data were analysed using WinMDI 2.8 software.
###end p 29
###begin title 30
Single nucleotide polymorphism bioinformatics analyses
###end title 30
###begin p 31
###xml 62 67 62 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF2R</italic>
###xml 200 205 200 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 193 211 193 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">Frazer <italic>et al</italic>. 2007</xref>
###xml 300 305 300 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 293 311 293 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib37">Packer <italic>et al</italic>. 2006</xref>
###xml 397 402 397 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 389 408 389 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">Kolonel <italic>et al</italic>. 2004</xref>
###xml 781 782 781 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 792 793 792 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 793 794 793 794 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 881 886 881 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 873 892 873 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">Barrett <italic>et al</italic>. 2005</xref>
The allele frequency of rs629849 and linkage disequilbrium of IGF2R around this SNP was investigated using publicly available genotype data from the HapMap (Han Chinese, Japanese, and Yoruba) (Frazer et al. 2007), SNP500Cancer (African/African American, Caucasian, Hispanic, and Pacific Rim) (Packer et al. 2006) and the Multi-Ethnic Cohort (Black, Hawaiian, Japanese, Latino, and White) (Kolonel et al. 2004). Haploview (version 4.1) was used to calculate measures of linkage disequilibrium (LD). These measures included absolute D' (a measure of the covariance of allele counts for two SNPs under the assumption of Hardy-Weinberg equilibrium), the 95% confidence intervals for D', LOD scores (log of the likelihood ratio, a measure of the confidence in the value of D'), and the R-squared (R2) statistic (correlation coefficient for the pairwise comparison of the SNPs) (Barrett et al. 2005).
###end p 31
###begin title 32
Results
###end title 32
###begin title 33
Structural location, conformation and modelling of Gly1619Arg
###end title 33
###begin p 34
###xml 242 247 242 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 233 253 233 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib43">Williams <italic>et al</italic>. 2007</xref>
###xml 261 266 261 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 255 272 255 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">Brown <italic>et al</italic>. 2008</xref>
###xml 512 518 512 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1</xref>
###xml 531 536 531 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 522 542 522 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib43">Williams <italic>et al</italic>. 2007</xref>
###xml 550 555 550 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 544 561 544 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">Brown <italic>et al</italic>. 2008</xref>
###xml 88 93 <span type="species:ncbi:9606">human</span>
###xml 188 193 <span type="species:ncbi:9606">human</span>
We first determined the localisation of Gly1619 in relation to the IGF2 binding site of human IGF2R domain 11. We utilised our high resolution NMR and X-ray crystallographic structures of human IGF2 bound to 11-13 of IGF2R at 4.1 A (Williams et al. 2007, Brown et al. 2008). Both the solution structure of domain 11 of IGF2R, and the modelled IGF2 binding interaction using HADDOCK, located Gly1619 in the GH loop region, distant from the cluster of differentiation, AB and FG that formed the IGF2 binding site (Fig. 1A) (Williams et al. 2007, Brown et al. 2008). IGF2 induced conformational changes in domain 11 structure detected by NMR were predominantly located in the binding loops (AB, cluster of differentiation and FG loops) rather than the carbon backbone of the beta-barrel structure.
###end p 34
###begin p 35
###xml 34 35 34 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 37 39 37 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15</sup>
###xml 205 211 205 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1</xref>
###xml 476 481 476 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 470 489 470 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">Brown <italic>et al</italic>. (2008)</xref>
###xml 683 689 683 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1</xref>
###xml 881 886 881 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 875 892 875 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">Brown <italic>et al</italic>. 2008</xref>
Detailed examination of domain 11 1H-15N heteronuclear single quantum coherence (HSQC) spectra showed that Arg1619 modification did not significantly alter protein conformation when compared with Gly1619 (Fig. 1B). Moreover, comparison of the crystal structures of ligand free domains of 11-14 at 2.9 A, and domains 11-13 with IGF2 bound at 4.1 A, also showed no conformational change in either the localisation or juxtaposition of G1619 (see Supplementary Figure S3 of Brown et al. (2008)). Modelling of the arginine replacement of glycine revealed a number of new potential electrostatic interactions with Glu1916 and Glu1915 of the fibronectin type II (FnII) domain of domain 13 (Fig. 1A). These new interactions may help to stabilise the fibronectin type II domain, and alter the orientation of the interaction with the AB loop of domain 11 that can modify IGF2 binding (Brown et al. 2008). The FnII residues interacting with the AB loop are on the same long loop as those that could possibly interact with Gly/Arg1619, namely Ser1921 and Arg1922, and possibly Trp1639. As a result of the location of Gly1619 between domain 11 and 12, it is also possible that Arg1619 may alter the conformation between domains on ligand binding of IGF2, which may not only alter IGF2 interactions with domain 11, but may also alter the subsequent binding of mannose 6-phosphate to domain 3, 5 and 9.
###end p 35
###begin title 36
Real-time analysis of IGF2 ligand binding using SPR
###end title 36
###begin p 37
###xml 439 444 439 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 431 450 431 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib50">Zaccheo <italic>et al</italic>. 2006</xref>
###xml 653 658 653 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 647 664 647 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">Brown <italic>et al</italic>. 2008</xref>
###xml 857 863 857 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pichia</italic>
###xml 863 871 863 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pastoris</italic>
###xml 968 973 968 973 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 960 979 960 979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib33">Linnell <italic>et al</italic>. 2001</xref>
###xml 989 994 989 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 981 1000 981 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib50">Zaccheo <italic>et al</italic>. 2006</xref>
###xml 1073 1079 1073 1079 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2</xref>
###xml 1410 1416 1409 1415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2</xref>
###xml 1606 1611 1605 1610 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1598 1617 1597 1616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib50">Zaccheo <italic>et al</italic>. 2006</xref>
###xml 1785 1792 1784 1791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 894 897 <span type="species:ncbi:10116">rat</span>
Analysis of the domain 11 structure suggested that the Gly1619Arg polymorphism may alter the IGF2 binding interaction indirectly by modifying the interaction between the AB loop of IGF2R domain 11 and the FnII domain of domain 13. We had previously mutated the AB loop residues and identified Glu1544 as an important residue in the interaction with IGF2, and when mutated to a Lys a sixfold enhanced affinity to IGF2 was observed (Zaccheo et al. 2006). Moreover, when we deleted the FnII domain in domain 13, we detected an increased 'off rate' of the interaction by tenfold with IGF2, which could be partially rescued by the Glu1544Lys mutation (Brown et al. 2008). By utilising protein expression systems we have previously described, we mutated Gly1619 to Arg using site directed mutagenesis, and expressed both soluble His- tagged IGF2R domain 11 using Pichiapastoris, and chimeric soluble rat CD4 tagged IGF2R domains 11, 10-13 and 1-15 using 293T cells (Linnell et al. 2001, Zaccheo et al. 2006). Proteins were expressed and single bands identified on western blots (Fig. 2A). Proteins were biotinylated and immoblised on BIAcore biosensor chips and recombinant IGF2 ligand was passed over the sensor surface at increasing concentration and at high flow-rates (40 mul/min). The resulting sensograms were fitted using a two-state conformational change model with BIA evalution software (examples shown in Fig. 2B-D). We had previously validated these biosensor kinetic assays and have shown them to be sensitive enough to detect subtle changes in binding kinetics with single point mutations (Zaccheo et al. 2006). Comparison of domain 11 alone, domains 10-13 and domains 1-15 with and without Gly1619Arg showed no significant difference in association and dissociation kinetics (Table 1). Moreover, when biotinylated IGF2 was immobilised, the binding profiles of soluble receptor constructs showed mass transport effects but no differences between Gly1619 and Arg1619, suggesting that differences were not masked by any tethering effect of immobilised receptors (not shown). Thus, we could not detect any difference in affinity between Gly1619 and Arg1619 using single and multiple domain recombinant proteins and SPR.
###end p 37
###begin title 38
Real-time analysis of mannose 6-phosphate ligand binding using SPR
###end title 38
###begin p 39
###xml 207 212 204 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 199 218 196 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib33">Linnell <italic>et al</italic>. 2001</xref>
###xml 228 233 225 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 220 239 217 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib50">Zaccheo <italic>et al</italic>. 2006</xref>
###xml 351 357 348 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3</xref>
###xml 437 444 434 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 645 650 636 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 639 655 630 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">Kiess <italic>et al</italic> 1989</xref>
###xml 657 661 648 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib28">1990</xref>
###xml 908 914 896 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4</xref>
###xml 975 981 963 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4</xref>
###xml 1113 1119 1098 1104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4</xref>
###xml 1238 1244 1220 1226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4</xref>
###xml 1632 1638 1608 1614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4</xref>
###xml 1907 1912 1883 1888 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1901 1918 1877 1894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">Kiess <italic>et al</italic>. 1989</xref>
###xml 1920 1924 1896 1900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib28">1990</xref>
We next tested the effects of the Gly1619Arg mutant domain 1-15 proteins on binding to mannose 6-phosphate. For this reaction, we utilised mannosylated latent-TGFbeta1 that we had previously tested (Linnell et al. 2001, Zaccheo et al. 2006). Concentration dependent binding sensorgrams were fitted using a global model (expected stoichiometry of 2:1, Fig. 3 representative sensorgrams) and association and dissociation rates calculated (Table 1). Again, we could not detect significant differences in binding to latent-TGFbeta1 alone. Previous reports suggested that binding of IGF2 and latent-TGFbeta1 to IGF2R may be mutually exclusive (Kiess et al 1989, 1990). In order to test the hypothesis that Gly1619Arg mutation might have altered these interactions, we designed an experiment where either IGF2 or latent-TGFbeta1 was pre-bound to immobilised biotinylated CD4-1-15 on a streptavidin biosensor chip (Fig. 4). Kinetics of binding to single analyte was first compared (Fig. 4A), before IGF2 was pre-bound at 130 nM (saturation concentration), followed by latent-TGFbeta1 (30 nM) combined with IGF2 (130 nM; Fig. 4B). Examination of sensorgrams revealed similar binding of latent-TGFbeta1 irrespective of whether IGF2 was pre-bound (Fig. 4B). However, when latent-TGFbeta1 was loaded on the sensor chip prior to IGF2, the subsequent binding of IGF2 was significantly impaired when co-injected with latent-TGFbeta1 or alone as a control, indicating that occupied mannose 6-phosphate binding sites impaired IGF2 binding. There were no significant differences in binding kinetics detected between Gly1619 (wild-type) and Arg1619 (Fig. 4C). Thus, we confirmed previous reports that mannose 6-phosphate binding may compete with the IGF2 interaction, an effect presumed to be due to steric hindrance, although indirect conformational changes in binding loops of domains 3 and 9 have not been excluded (Kiess et al. 1989, 1990).
###end p 39
###begin title 40
Expression and half-life of IGF2R Gly1619 and Arg1619 in mammalian cells
###end title 40
###begin p 41
###xml 382 387 382 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 376 393 376 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">Davis <italic>et al</italic>. 1990</xref>
###xml 403 408 403 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 395 414 395 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib33">Linnell <italic>et al</italic>. 2001</xref>
###xml 498 504 498 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5</xref>
###xml 808 832 808 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Clairmont and Czech 1991</xref>
###xml 918 923 918 923 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 909 929 909 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib35">Nakayama <italic>et al</italic>. 2004</xref>
###xml 938 943 938 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 931 949 931 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib40">Sharma <italic>et al</italic>. 2004</xref>
In order to determine whether the polymorphism altered either RNA or protein stability, we transiently over-expressed both soluble and membrane bound versions of IGF2R domains 1-15 in 293T cells. Messenger RNA expression and protein levels were quantified using quantitative RT-PCR and a previously described CD4 inhibition ELISA (for soluble CD4-1-15 proteins) respectively (Davis et al. 1990, Linnell et al. 2001). No significant changes in mRNA levels and 1-15 protein constructs were detected (Fig. 5A and C), although a significant relative reduction in level of the CD4-10-13 Arg1619 and CD4-1-15 Arg1619 was observed. It was possible that either selective proteolysis or alteration in protein half-life accounted for these results with CD4 chimeric proteins, the former a mechanism of IGF2R turnover (Clairmont and Czech 1991), the latter having been described for mutations of the membrane receptors (Nakayama et al. 2004, Sharma et al. 2004).
###end p 41
###begin p 42
###xml 65 67 65 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 805 811 805 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6</xref>
###xml 1089 1095 1089 1095 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6</xref>
In order to further investigate these results, we next performed 35S-methionine pulse-chase experiments in 293T cells transiently transfected with CD4-1-15 Gly1619 and CD4-1-15 Arg 1619 to generate soluble proteins, and 1-15Gly1619 and 1-15Arg1619 to generate membrane bound proteins. Cell lysate and supernatant samples were immuno-precipitated with antibodies to either CD4 or IGF2R depending on whether soluble or membrane bound proteins were expressed respectively. SDS protein gels were exposed and quantified by phosphorimaging, and radioactivity expressed relative to a control of the total radioactivity in the sample. Following a 1 h pulse and 96 h chase, soluble CD4-1-15 proteins were chased into the supernatants from cell lysates with similar kinetics and levels between Gly1619 and Arg1619 (Fig. 6A and B). For membrane bound proteins, a 12 h pulse resulted in higher radio-labelled protein levels in cell lysates compared with a 1 h pulse, with no significant overall differences observed between Gly1619 and Arg1619 half-life in cell lysates and cell culture supernatants (Fig. 6C-F). We concluded that differences in protein abundance observed following transient transfection were not related to altered half-life of IGF2R proteins.
###end p 42
###begin title 43
Surface membrane distribution of IGF2R protein
###end title 43
###begin p 44
###xml 516 522 516 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7</xref>
###xml 255 260 <span type="species:ncbi:10090">mouse</span>
###xml 266 271 <span type="species:ncbi:9606">human</span>
Finally, we utilised membrane bound 1-15 Gly1619 and Arg1619 co-expressed with eGFP reporter plasmid following transient co-transfection in order to determine whether membrane distribution of IGF2R was altered. Immuno-fluorescence of unfixed cells with a mouse anti-human IGF2R antibody did not show altered distribution with Arg1619 (not shown). Two colour flow cytometry was then utilised to quantify surface expression of IGF2R in unfixed 293T cells and total IGF2R in cells that had been fixed and permeablised (Fig. 7). Following control transfections to set thresholds of detection (not shown), eGFP positive and PE/Cy5 anti-IGF2R positive cells were quantified, and again showed no differences in abundance and membrane protein localisation between genotypes.
###end p 44
###begin title 45
Genetic variation around IGF2R Gly1619Arg
###end title 45
###begin p 46
###xml 371 378 371 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">Table 2</xref>
###xml 92 97 <span type="species:ncbi:9606">human</span>
The frequency of the rs624849, Exon 34-93 A>G, Gly1619Arg SNP is variable between different human populations. Using publicly available databases, population-specific genetic variation and linkage disequilibrium (LD) of Gly1619Arg was evaluated. The frequency of the A allele ranged from 0 in the HapMap Yoruba subjects to 0.25 in Pacific Rim subjects from SNP500Cancer (Table 2). This SNP was not in Hardy-Weinberg equilibrium in Caucasian subjects from both HapMap and SNP500Cancer.
###end p 46
###begin p 47
###xml 176 177 176 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 177 178 177 178 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 226 227 226 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 227 228 227 228 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 384 391 384 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl3">Table 3</xref>
LD was assessed between rs629849 and SNPs 20 kb upstream and downstream of rs629849 with minor allele frequencies greater than or equal to 0.01. rs629849 was not in strong LD (R2>0.8) with any SNPs in these regions. SNPs with R2 values greater than 0.3 and D' values >0.8, suggestive, but not strongly supportive of LD, were noted in subjects of Asian descent from HapMap and SNP500 (Table 3). These SNPs were in nearby introns.
###end p 47
###begin title 48
Discussion
###end title 48
###begin p 49
###xml 120 125 120 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 115 131 115 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib42">Wang <italic>et al</italic>. 1994</xref>
###xml 140 145 140 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 133 151 133 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">Ludwig <italic>et al</italic>. 1996</xref>
###xml 159 164 159 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 153 170 153 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib45">Wylie <italic>et al</italic>. 2003</xref>
###xml 323 328 323 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 314 334 314 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">De Souza <italic>et al</italic>. 1995</xref>
###xml 344 349 344 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 336 355 336 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">Hankins <italic>et al</italic>. 1996</xref>
###xml 362 367 362 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 357 373 357 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">Byrd <italic>et al</italic>. 1999</xref>
###xml 380 385 380 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 375 391 375 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">Kong <italic>et al</italic>. 2000</xref>
###xml 224 229 <span type="species:ncbi:9606">human</span>
###xml 678 683 <span type="species:ncbi:9606">human</span>
Disruption of the function of IGF2R has potent consequences for IGF2 dependent overgrowth of the mammalian embryo (Wang et al. 1994, Ludwig et al. 1996, Wylie et al. 2003). Frequent mutation and loss of function of IGF2R in human tumours have also implicated the selective growth advantage of cells lacking IGF2R (De Souza et al. 1995, Hankins et al. 1996, Byrd et al. 1999, Kong et al. 2000). Of the ligands that bind IGF2R, IGF2 appeared to be the most potent in terms of gross effects on growth control. As IGF2 binds IGF2R at a selective binding site in domain 11, and with high affinity, any non-synonymous polymorphisms of this domain remain strong candidate modifiers of human embryonic and tumour growth.
###end p 49
###begin p 50
###xml 414 438 414 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">Clairmont and Czech 1989</xref>
###xml 448 453 448 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 440 459 440 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib47">Yandell <italic>et al</italic>. 1999</xref>
###xml 467 472 467 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 461 478 461 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">Brown <italic>et al</italic>. 2002</xref>
###xml 480 484 480 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">2008</xref>
###xml 1130 1135 1130 1135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1122 1141 1122 1141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib50">Zaccheo <italic>et al</italic>. 2006</xref>
###xml 393 400 <span type="species:ncbi:9031">chicken</span>
A number of observational approaches have been taken to assess the functional significance of the 1619 position of domain 11 of IGF2R. During evolution of IGF2R, the receptor acquired an IGF2 ligand binding function that was associated with a number of amino acid mutations of the domain 11 binding site, yet Gly1619 appeared to be a highly conserved amino acid during the evolution of birds (chicken) to mammals (Clairmont and Czech 1989, Yandell et al. 1999, Brown et al. 2002, 2008). This evolutionary observation suggested that the non-synonymous SNP at 1619 would be unlikely to be involved in a direct interaction with IGF2. Our structural studies have also supported this notion, as the 1619 residue was remotely located with respect to the IGF2 binding site. In addition, IGF2 induced conformational changes in the binding site loop residues but not the 1619 residue, and suggested that any effect on IGF2 binding was likely to be indirect. Modelling of Arg1619 supported potential indirect effects on the FnII domain that subsequently may have lead to alteration of binding site interactions through the AB loop (Zaccheo et al. 2006). These observations led us to directly mutate Gly1619 to Arg1619 and to compare receptor function.
###end p 50
###begin p 51
###xml 293 298 293 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 287 304 287 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib38">Petry <italic>et al</italic>. 2005</xref>
###xml 542 547 542 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 538 553 538 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31 bib36">Ong <italic>et al</italic>. 2000</xref>
###xml 563 568 563 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 555 574 555 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">Garrone <italic>et al</italic>. 2002</xref>
###xml 746 751 746 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 740 759 740 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib38">Petry <italic>et al</italic>. (2005)</xref>
###xml 846 851 846 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 841 857 841 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">Kaku <italic>et al</italic>. 2007</xref>
###xml 31 36 <span type="species:ncbi:9606">human</span>
###xml 524 529 <span type="species:ncbi:9606">human</span>
A report had correlated slower human childhood growth rate in the rare IGF2R Arg1619 (A/A) homozygotes, yet our data suggested that this amino acid change alone was non-functional in terms of IGF2 and mannose 6-phosphate ligand binding, protein half-life and cell membrane distribution (Petry et al. 2005). It is important to state that the implications of our experiments do not alter the interpretation of the positive correlation between circulating concentrations of IGF2, and inverse correlation with soluble IGF2R and human growth (Ong et al. 2000, Garrone et al. 2002). However, our data make it difficult to directly attribute the phenotypic growth effects with Gy1619Arg to IGF2R receptor function. Even though the observations of Petry et al. (2005) are unconfirmed, our observations do not alter the Arg1619 correlation observed (Kaku et al. 2007), as there are a number of potential explanations that might reconcile these sets of data.
###end p 51
###begin p 52
###xml 764 769 764 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 758 775 758 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib19">Ghosh <italic>et al</italic>. 2003</xref>
###xml 1224 1237 1224 1237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR2-Val64Ile</italic>
###xml 1391 1396 1391 1396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1382 1402 1382 1402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib35">Nakayama <italic>et al</italic>. 2004</xref>
###xml 1444 1448 1444 1448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 1555 1560 1555 1560 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1548 1566 1548 1566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib40">Sharma <italic>et al</italic>. 2004</xref>
###xml 2031 2036 2031 2036 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 2022 2042 2022 2042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib32">Kreiling <italic>et al</italic>. 2005</xref>
###xml 2312 2317 2312 2317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 2303 2323 2303 2323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib32">Kreiling <italic>et al</italic>. 2005</xref>
###xml 2331 2336 2331 2336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 2325 2342 2325 2342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">Brown <italic>et al</italic>. 2008</xref>
###xml 2525 2530 2525 2530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 2520 2536 2520 2536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib48">York <italic>et al</italic>. 1999</xref>
###xml 2543 2548 2543 2548 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 2538 2554 2538 2554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">Byrd <italic>et al</italic>. 2000</xref>
###xml 2942 2947 2942 2947 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 2936 2954 2936 2954 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">Brown <italic>et al</italic>. (2008</xref>
###xml 1350 1353 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1363 1369 <span type="species:ncbi:9606">humans</span>
Firstly, it was possible the assays we utilised may have been insensitive to subtle changes in receptor function. For real-time analysis of recombinant protein interactions, we are confident that the validated approach taken here would have been sensitive enough to define functional variation, such as the fundamental binding interaction between IGF2 and IGF2R. This was unaltered between Gly1619 and Arg1619. Importantly, we have also shown that the competitive binding between mannose 6-phosphate and IGF2 binding was also unaltered. As IGF2R cycles between the endoplasmic reticulum, Golgi and the pre-lysosomal compartment, it was possible that modified function may have occurred as a result of either altered trafficking, distribution or proteolysis (Ghosh et al. 2003). It is well established that the trafficking and distribution functions of IGF2R depend on the cytoplasmic domain that is remotely located with respect to 1619, which meant that it would have been highly unlikely that Gly1619Arg would have altered trafficking. However, several important non-synonymous polymorphisms of membrane receptors have functional effects that were related to altered protein half-life. For example, the chemokine receptor CCR2-Val64Ile polymorphism resulted in protein with prolonged half-life that had explained the delayed progression to AIDS in HIV infected humans with 64Ile (Nakayama et al. 2004). In addition, deletion of Phe508 of the CFTR gene leads to cystic fibrosis because of altered folding, stability and plasma membrane half-life (Sharma et al. 2004). Here, we directly addressed this question and performed quantitative pulse-chase and flow cytometry experiments that suggested that Gly1619Arg did not significantly alter the rate of protein production, processing, proteolysis and membrane distribution. The only remaining functional mechanism that we did not directly test was the potential interaction of residue 1619 with domain 12, and the potential for indirect modification of IGF2R dimerisation (Kreiling et al. 2005). We have previously detected dimerisation of 1-4% of recombinant domain 11-12 and 11-13 using analytical ultracentrifugation, corroborating our observation of structural juxtaposition of domain 12 in crystals and the data obtained using epitope tagged IGF2R (Kreiling et al. 2005, Brown et al. 2008). Ligand binding does not alter the ability of IGF2R to dimerise, but dimerisation may improve the avidity of the receptor for ligands and increase the rate of internalisation (York et al. 1999, Byrd et al. 2000). Detailed examination of our crystal structures confirmed that Gly1619R was remote from the hydrophobic dimerisation surface in domain 12 that involved Pro1755 and Tyr1741, and that there appeared no conformational change in position of 1619 when comparing crystals from domains 11-12 (where there is no dimerisation) with those of 11-13 (where there is dimersiation) (not shown, Brown et al. (2008)). These observations suggested that Gly1619Arg would be unlikely to alter the extent and stability of IGF2R dimerisation, particularly as multiple domain interactions that regulate dimerisation avidity between full length receptors.
###end p 52
###begin p 53
###xml 294 300 294 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig8">Fig. 8</xref>
###xml 1048 1053 1048 1053 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1041 1059 1041 1059 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib39">Savage <italic>et al</italic>. 2007</xref>
Our data leads us to conclude that the Gly1619Arg polymorphism is non-functional. It is possible that there could be interactions with other non-synonymous SNPs. For example, the location of the Gln1696Arg (rs11552587) residue appeared closely localised to Gly1619Arg in the crystal structure (Fig. 8), and may directly interact to modify function. However, this SNP is very rare in the populations examined so far (e.g. 0.009 allelic frequency in the Yoruba) and means that it was unlikely that this interaction would be significant. However, it is possible that in certain populations the rs629849 SNP is in LD with others that could contribute to differential function or expression of the IGF2R gene. Importantly, the SNPs with suggested LD with the Gly1619Arg polymorphism were in intronic sequences and could possibly affect intron-exon splice sites. Functional associations need not be correlated with exon SNPs, as functional consequences may occur as a result of intron SNPs, for example recently implicated in altered methylation (Savage et al. 2007). Alternatively, other non-synonymous SNPs in other regions of the protein may result in unpredictable functional changes. In order to completely understand the complex function of the IGF2R protein and the effect of genetic polymorphisms on its function, further experimental evaluation of IGF2R polymorphisms are warranted.
###end p 53
###begin title 54
Declaration of interest
###end title 54
###begin p 55
The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.
###end p 55
###begin title 56
Funding
###end title 56
###begin p 57
Supported by Cancer Research UK (C429, C375), Wellcome Trust and NIH. This research was supported (in part) by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics.
###end p 57
###begin title 58
Acknowledgements
###end title 58
###begin p 59
We thank James Brown, Emily Foulstone, David Barnes and John Crosby for discussion, Cancer Research UK (ABH- C429, EYJ-C375), Wellcome Trust UK (MC-082352) and an Algerian Ministry of Higher Education Scholarship (DR) for funding.
###end p 59
###begin title 60
References
###end title 60
###begin article-title 61
Haploview: analysis and visualization of LD and haplotype maps
###end article-title 61
###begin article-title 62
Structure of a functional IGF2R fragment determined from the anomalous scattering of sulfur
###end article-title 62
###begin article-title 63
Structure and functional analysis of the IGF-II/IGF2R interaction
###end article-title 63
###begin article-title 64
Disruption of ligand binding to the insulin-like growth factor II/mannose 6-phosphate receptor by cancer-associated missense mutations
###end article-title 64
###begin article-title 65
Dimerization of the insulin-like growth factor II/mannose 6-phosphate receptor
###end article-title 65
###begin article-title 66
A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis
###end article-title 66
###begin article-title 67
###xml 0 7 <span type="species:ncbi:9031">Chicken</span>
###xml 12 19 <span type="species:ncbi:8355">Xenopus</span>
Chicken and Xenopus mannose 6-phosphate receptors fail to bind insulin-like growth factor II
###end article-title 67
###begin article-title 68
Extracellular release as the major degradative pathway of the insulin-like growth factor II/mannose 6-phosphate receptor
###end article-title 68
###begin article-title 69
Metalloproteinase pregnancy-associated plasma protein A is a critical growth regulatory factor during fetal development
###end article-title 69
###begin article-title 70
Loss of IGF2 imprinting: a potential marker of colorectal cancer risk
###end article-title 70
###begin article-title 71
###xml 25 40 <span type="species:ncbi:10029">Chinese hamster</span>
High level expression in Chinese hamster ovary cells of soluble forms of CD4 T lymphocyte glycoprotein including glycosylation variants
###end article-title 71
###begin article-title 72
###xml 29 34 <span type="species:ncbi:9606">human</span>
M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity
###end article-title 72
###begin article-title 73
NMRPipe: a multidimensional spectral processing system based on UNIX pipes
###end article-title 73
###begin article-title 74
Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor
###end article-title 74
###begin article-title 75
###xml 116 121 <span type="species:ncbi:9606">human</span>
Altered ligand binding by insulin-like growth factor II/mannose 6-phosphate receptors bearing missense mutations in human cancers
###end article-title 75
###begin article-title 76
Insulin-like growth factor ligands, receptors, and binding proteins in cancer
###end article-title 76
###begin article-title 77
###xml 20 25 <span type="species:ncbi:9606">human</span>
A second generation human haplotype map of over 3.1 million SNPs
###end article-title 77
###begin article-title 78
###xml 117 125 <span type="species:ncbi:9606">children</span>
Increased insulin-like growth factor (IGF)-II and IGF/IGF-binding protein ratio in prepubertal constitutionally tall children
###end article-title 78
###begin article-title 79
Mannose 6-phosphate receptors: new twists in the tale
###end article-title 79
###begin article-title 80
Identification of residues essential for carbohydrate recognition by the insulin-like growth factor II/mannose 6-phosphate receptor
###end article-title 80
###begin article-title 81
Localization of the carbohydrate recognition sites of the insulin-like growth factor II/mannose 6-phosphate receptor to domains 3 and 9 of the extracytoplasmic region
###end article-title 81
###begin article-title 82
M6P/IGF2, receptor: a candidate breast tumor suppressor gene
###end article-title 82
###begin article-title 83
Soluble IGF2 receptor rescues Apc(Min/+) intestinal adenoma progression induced by Igf2 loss of imprinting
###end article-title 83
###begin article-title 84
Somatically acquired hypomethylation of IGF2 in breast and colorectal cancer
###end article-title 84
###begin article-title 85
Insulin-like growth factor 2 (IGF2) and IGF2 receptor gene variants are associated with fetal growth
###end article-title 85
###begin article-title 86
###xml 72 77 <span type="species:ncbi:10090">mouse</span>
###xml 89 95 <span type="species:ncbi:9606">humans</span>
The insulin-like growth factor type-2 receptor gene is imprinted in the mouse but not in humans
###end article-title 86
###begin article-title 87
Insulin-like growth factor-II (IGF-II) inhibits both the cellular uptake of beta-galactosidase and the binding of beta-galactosidase to purified IGF-II/mannose 6-phosphate receptor
###end article-title 87
###begin article-title 88
Beta-galactosidase decreases the binding affinity of the insulin-like-growth-factor-II/mannose-6-phosphate receptor for insulin-like-growth-factor II
###end article-title 88
###begin article-title 89
Mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) variants in American and Japanese populations
###end article-title 89
###begin article-title 90
The multiethnic cohort study: exploring genes, lifestyle and cancer risk
###end article-title 90
###begin article-title 91
RLM6P/IGF2R, is mutated in squamous cell carcinoma of the lung
###end article-title 91
###begin article-title 92
Domain interactions of the mannose 6-phosphate/insulin-like growth factor II receptor
###end article-title 92
###begin article-title 93
Real time kinetics of insulin-like growth factor II (IGF-II) interaction with the IGF-II/mannose 6-phosphate receptor: the effects of domain 13 and pH
###end article-title 93
###begin article-title 94
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds
###end article-title 94
###begin article-title 95
A CCR2-V64I polymorphism affects stability of CCR2A isoform
###end article-title 95
###begin article-title 96
###xml 196 201 <span type="species:ncbi:9606">human</span>
###xml 202 209 <span type="species:ncbi:9606">infants</span>
Size at birth and cord blood levels of insulin, insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-1 (IGFBP-1), IGFBP-3, and the soluble IGF-II/mannose-6-phosphate receptor in term human infants, The ALSPAC study team. Avon longitudinal study of pregnancy and childhood
###end article-title 96
###begin article-title 97
SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes
###end article-title 97
###begin article-title 98
Genetic variation in the type 2 insulin-like growth factor receptor gene and disparity in childhood height
###end article-title 98
###begin article-title 99
Analysis of genes critical for growth regulation identifies Insulin-like Growth Factor 2 Receptor variations with possible functional significance as risk factors for osteosarcoma
###end article-title 99
###begin article-title 100
Misfolding diverts CFTR from recycling to degradation: quality control at early endosomes
###end article-title 100
###begin article-title 101
The CCPN, data model for NMR spectroscopy: development of a software pipeline
###end article-title 101
###begin article-title 102
Regulation of embryonic growth and lysosomal targeting by the imprinted Igf2/Mpr gene
###end article-title 102
###begin article-title 103
Structural insights into the interaction of insulin-like growth factor 2 with IGF2R domain 11
###end article-title 103
###begin article-title 104
###xml 80 84 <span type="species:ncbi:10090">mice</span>
Non-imprinted Igf2r expression decreases growth and rescues the Tme mutation in mice
###end article-title 104
###begin article-title 105
###xml 32 38 <span type="species:ncbi:10090">murine</span>
Tissue-specific inactivation of murine M6P/IGF2R
###end article-title 105
###begin article-title 106
###xml 58 63 <span type="species:ncbi:9606">human</span>
Functional polymorphism in the parental imprinting of the human IGF2R gene
###end article-title 106
###begin article-title 107
###xml 4 12 <span type="species:ncbi:9322">kangaroo</span>
The kangaroo cation-independent mannose 6-phosphate receptor binds insulin-like growth factor II with low affinity
###end article-title 107
###begin article-title 108
The rate of internalization of the mannose 6-phosphate/insulin-like growth factor II receptor is enhanced by multivalent ligand binding
###end article-title 108
###begin article-title 109
###xml 69 74 <span type="species:ncbi:9940">sheep</span>
Epigenetic change in IGF2R is associated with fetal overgrowth after sheep embryo culture
###end article-title 109
###begin article-title 110
###xml 85 90 <span type="species:ncbi:9606">human</span>
Kinetics of insulin-like growth factor II (IGF-II) interaction with domain 11 of the human IGF-II/mannose 6-phosphate receptor: function of CD and AB loop solvent-exposed residues
###end article-title 110
###begin p 111
###xml 471 472 468 469 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 474 476 471 473 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15</sup>
###xml 605 606 596 597 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 668 669 659 660 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
Structural localisation of Gly1619 of IGF2R domain 11. (A) Crystal structure of IGF2R domain 11-13 bound to IGF2(2) (PDB: 2V5P). Gly1619 is located in a long loop between beta-strands G and H. Modelling of the arginine replacement of glycine (Gly1619Arg) suggests that the Gly1619Arg polymorphism may interact with a group of charged residues of the fibronectin type II (FnII) domain of domain 13, rendered as pink sticks, e.g. Glu1916 and Glu1915. (B) Comparison of the 1H-15N HSQC spectra of wild-type (Gly1619, black) and Arg1619 (red) domain 11 recorded at 600 MHz at pH5.5, 25 degreesC. Side chain NH2 groups of Asn and Gln are indicated by lines parallel to the 1H axis and the Gly1619Arg polymorphism is boxed. Changes in the spectra due to differences in the constructs are highlighted with an asterisk.
###end p 111
###begin p 112
###xml 1121 1128 1121 1128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
Protein expression and real-time kinetic analysis of wild-type and Gly1619Arg IGF2R binding to IGF2. (A) Western blot detection of the expressed and biotinylated recombinant proteins. Soluble CD4 chimeric proteins were biotinylated, subjected to SDS-PAGE and directly probed with streptavidin conjugated to alkaline phosphatase. (B) Representative sensorgrams depicting injections of recombinant IGF2 at 2, 4, 8, 16, 33 and 134 nM binding to immobilised CD4-11 chimeric proteins; WT domain 11 (WT 11) and Gly1619Arg (abbreviated to G1619R) domain 11 (G1619R 11). (C) and (D) Representative sensorgrams depicting duplicate injections of recombinant IGF2 at 0.2, 0.5, 1, 2, 4, 8, 16, 32, 64, 128 nM binding to CD4-11 chimeric proteins; wild-type recombinant 10-13 domains (WT 10-13), Gly1619Arg recombinant 10-13 domains (Gly1619Arg 10-13), wild-type recombinant 1-15 domains (WT 1-15) and Gly1619Arg recombinant 1-15 domains (G1619R 1-15). Constructs and ranges of analyte concentrations are indicated. Grey lines represent the global fitting of the data set to a two-state (conformational change) binding model (see also Table 1).
###end p 112
###begin p 113
###xml 579 586 573 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
Real-time kinetic evaluation of the binding of latent-TGFbeta1 to wild-type and G1619R IGF2R domains 1-15. Representative sensorgrams depicting duplicate injections of recombinant latent TGFbeta1 at 0.18, 0.37, 0.75, 1.5, 3, 6, 12 and 24 nM binding to immobilised CD4-11 chimeric proteins; wild-type recombinant 1-15 domains (WT 1-15) (A) and Gly1619Arg recombinant 1-15 domains (G1619R 1-15) (B). Constructs and ranges of analyte concentrations are indicated. Grey lines represent the global fitting of the data using a two-state (conformational change) binding model (see also Table 1).
###end p 113
###begin p 114
Real-time kinetic evaluation of IGF2 and latent-TGFbeta1 competition binding to CD4-chimeric wild-type and G1619R IGF2R domains 1-15. (A) Representative sensorgrams of control 100 mul injections of HBS-EP buffer followed by 100 mul of HBS-EP buffer containing a single analyte, with subsequent binding to immobilised recombinant CD4-chimeric Gly1619 1-15 domains (WT, 1-15) and Arg1619 1-15 domains (G1619R 1-15). 130 nM IGF2 in buffer (black lines), 30 nM latent-TGFbeta1 in buffer (red lines) are shown together. (B) The effect of IGF2 pre-binding on the subsequent latent-TGFbeta1 binding to WT 1-15 and Gly1619Arg 1-15. Representative sensorgrams are shown. Initial injections of IGF2 (130 nM) alone were followed either by injection of the same concentration of IGF2 (130 nM) in buffer (black lines) or 130 nM IGF2 with 30 nM latent-TGFbeta1 (red lines). Similar latent-TGFbeta1 binding profiles were observed. (C) The effect of latent-TGFbeta1 pre-binding on the subsequent IGF2 binding to WT 1-15 and Gly1619 Arg 1-15. Injections of latent-TGFbeta1 (30 nM) were either followed by injection of 30 nM latent-TGFbeta1 in buffer (red lines), 30 nM latent-TGFbeta1 plus 130 nM IGF2 (black lines) or 130 nM IGF2 only as control (blue lines). The expected binding profile of IGF2 was not detected, and the extent of inhibition was similar in Gly1619 and Arg1619.
###end p 114
###begin p 115
###xml 363 369 361 367 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">s.e.m.</sc>
###xml 763 769 759 765 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">s.e.m.</sc>
###xml 800 801 796 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 842 843 838 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1051 1057 <span type="species:ncbi:9986">rabbit</span>
###xml 1063 1068 <span type="species:ncbi:9606">human</span>
###xml 1105 1111 <span type="species:ncbi:9986">rabbit</span>
Quantification of mRNA and protein levels in 293T cells transfected with wild-type (WT) and Gly1619Arg IGF2R CD4-1-15. (A) Relative expression of CD4-IGF2R Gly1619Arg mRNA relative to wild-type (1-15 and 10-13) using quantitative RT-PCR. Three separate single comparisons with single value WT taken arbitrarily as 1 and G1619R taken as a ratio. Values are mean+/-s.e.m. of three different experiments. Expression was normalised relative to GAPDH. The efficiency of the conducted PCR experiments, as assessed from standard curves, was between 95 and 100%. (B) Quantification of expressed soluble proteins using a CD4 inhibition ELISA suggested that there was no difference in CD4-1-15 proteins but potentially reduced relative amounts of CD4-10-13 Arg1619. Mean+/-s.e.m. of six different experiments. P values * 0.043, ** 0.015 using students t-test. (C) Western blot of endogenous and over-expressed wild-type and G1619R membrane bound IGF2R 1-15 (non-CD4 chimeric) in transfected 293T cell lysates. Samples were subjected to SDS-PAGE and probed with rabbit anti-human IGF2R. The blot was re-probed using rabbit anti-E-cadherin loading control.
###end p 115
###begin p 116
###xml 7 9 7 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 250 252 250 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 269 271 269 271 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 748 750 748 750 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 831 833 831 833 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 1208 1210 1207 1209 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 1227 1229 1226 1228 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 1697 1699 1696 1698 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 1788 1790 1787 1789 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 442 447 <span type="species:ncbi:10090">mouse</span>
###xml 453 456 <span type="species:ncbi:10116">rat</span>
###xml 1373 1378 <span type="species:ncbi:10090">mouse</span>
###xml 1384 1389 <span type="species:ncbi:9606">human</span>
IGF2R [35S] radiolabelled pulse-chase in transfected 293T cells. (A and B) Soluble CD4-IGF2R chimeric proteins. Pulse-chase analysis of IGF2R wild-type and Gly1619Arg CD4-1-15 processing by 293T cells transiently transfected and pulsed for 1 h with [35S]-cysteine and [35S]-methionine, and chased in cold media as described in methods. Supernatants and cell lysates were collected at chase time points as indicated, immuno-precipitated using mouse anti-rat CD4 antibody, and subjected to SDS-PAGE. Controls were either cell lysates or supernatants of non-transfected 293T cells. Densitometry data (B) were obtained from phosphor-imager scanned protein bands (times as indicated) and measured using ImageQuant software and normalised against total [35S] liquid scintillation per chase sample (A). (B) Upper curves depict the total [35S] liquid scintillation counts of 50 mul samples of corresponding cell lysates. (C-F) Membrane bound non-CD4 IGF2R. Pulse-chase analysis of wild-type and Gly1619Arg membrane bound 1-15 IGF2R (non-CD4 chimeric) processing by 293T cells. Transiently transfected 293T cells that expressed wild-type or Gly1619Arg 1-15 IGF2R were pulsed for 1 h (C and D) or 12 h (E and F) with [35S]-cysteine and [35S]-methionine, then chased in cold media. Cell lysates were collected at various chase time points (as indicated) and immuno-precipitated using mouse anti-human IGF2R antibody, and then subjected to SDS-PAGE to detect 1-15 IGF2R. Controls are cell lysates of non-transfected 293T cells and pre-pulse samples (Pre) were taken prior to metabolic labelling. Again, example phosphor-images (C and E) were quantified using ImageQuant software and normalised against total [35S] liquid scintillation per chase sample. (D) and (F) The upper curves depict the total [35S] liquid scintillation counting of 50 mul cell lysates and the lower curves depict the relative band intensity.
###end p 116
###begin p 117
###xml 824 830 822 828 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">s.e.m.</sc>
###xml 832 833 830 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 462 467 <span type="species:ncbi:10090">mouse</span>
###xml 473 478 <span type="species:ncbi:9606">human</span>
###xml 528 532 <span type="species:ncbi:9925">goat</span>
###xml 538 543 <span type="species:ncbi:10090">mouse</span>
Flow cytometry of anti-IGF2R labelled 293T cells over-expressing membrane bound IGF2R domains 1-15. 293T cells were co-transfected with membrane bound (non-CD4 chimeric) IGF2R 1-15 (pcDNA IGF2R) and eGFP (pEGFP-N1) plasmids as described in methods. Forty-eight h post-transfection, cells were either fixed with paraformaldehyde (2% w/v) or permeablised with Triton X100 (0.1% v/v) (A) or fixed with 4% (w/v) paraformaldehyde alone (B). Cells were incubated with mouse anti-human IGF2R, detected using PE/Cy5 secondary antibody (goat anti-mouse), co-labelling data collected with a FACSCalibur flow cytometer with minimal compensation, and then analysed using WinMDI 2.8 software. Non-transfected and secondary antibody controls were used to set background thresholds (not shown) Geometric means of staining are expressed +/-s.e.m. (n=5).
###end p 117
###begin p 118
Structural localisation of Gln1696Arg and Gly1619Arg. The rare SNP (rs11552587) results in a non-synonymous polymorphism Gln1696Arg that modifies an amino acid that also locates close to Gly1619Arg in the region between domains 11, 12 and 13. Other potential non-synonymous amino acids are also shown (Gln/Q1832, Asp/D1514), but none are in linkage disequilibrium with rs629849.
###end p 118
###begin p 119
BIAcore kinetic analysis of IGF2 and latent TGFbeta1 binding to recombinant IGF2R chimeric domains
###end p 119
###begin p 120
Genetic variation of rs629849 (Ex34-93 A>G, Gly1619Arg) amongst populations
###end p 120
###begin p 121
Data from CEPH Caucasians were not available from HapMap.
###end p 121
###begin p 122
rs629849 was not in Hardy-Weinberg equilibrium in this group.
###end p 122
###begin p 123
Single nucleotide polymorphisms in linkage disequilibrium with rs629849 (Ex34-93 A>G, Gly1619Arg)
###end p 123
###begin p 124
###xml 164 165 162 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 165 166 163 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 365 366 363 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 366 367 364 365 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
SNPs with minor allele frequencies >/= 0.01 20 kb upstream and downstream of rs629849 were evaluated for linkage disequilibrium in the populations shown. SNPs with R2 values >0.3 are reported. Abbreviations: SNP, single nucleotide polymorphism; CI, confidence interval for D'; LOD score, log of the likelihood ratio, a measure of the confidence in the value of D'; R2, the correlation coefficient between the two loci.
###end p 124

